3.2. Parallel Artificial Membrane Permeability ASSAY (PAMPA BBB)

AM Anna Makuch-Kocka
MA Marta Andres-Mach
MZ Mirosław Zagaja
Anna Śmiech
MP Magdalena Pizoń
JF Jolanta Flieger
JC Judyta Cielecka-Piontek
TP Tomasz Plech
request Request a Protocol
ask Ask a question
Favorite

BBB permeability of the compounds was investigated by using a PAMPA method (parallel artificial membrane permeability assay). The PAMPA system consisted of a 96-well microfilter plate and a 96-well filter plate and was divided into two chambers: a donor at the bottom and an acceptor at the top, separated by a 120-μm-thick microfilter disc coated with BBB lipid solution (Pion, Inc.). The solutions of each compound were prepared in dimethyl sulfoxide (DMSO) at 4 mg/mL concentration and then diluted with Prisma buffer (pH = 7.4) to obtain the donor drug solution with the final nominal concentration of 20 µg/mL. The donor solutions were placed on the donor plate. Acceptor plate contained Brain Sink Buffer (BSB). The plates were put together and incubated at 37 °C for 180 min in a humidity-saturated atmosphere. The concentrations of the compounds were determined with a UV-reader (Multiskan GO, Thermo Scientific) at 254 nm in the donor and acceptor compartments.

The permeability values (Pe) were calculated by using the following equation:

where VD: donor volume, VA: acceptor volume, Cequilibrium: equilibrium concentration Cequilibrium=CD×VD+ CA×VAVD+VA, CD: donor concentration, CA: acceptor concentration, S: membrane area, and t: incubation time (in seconds). High BBB permeation (CNS+) was expected for compounds with Pe > 5.19, whereas low BBB permeation (CNS-) was expected for compounds with Pe < 2.07 [21].

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A